In human breast cancer and Idiopathic pulmonary fibrosis, miR-96 directly targets the 3′UTR of the FOXO3a mRNA, which consequently decreases the expression of FOXO3a targets (p27 and p21) and increasing cyclin D1 [32, 33]. Here, FOXO3 is linked to pulmonary fibrosis.